Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD

Kidney International

Volumn 54, Issue 2, 1998, Pages 608-617

  Ambrosch, Andreas ^a   Domroese, Ute ^b   Westphal, Sabine ^b   Dierkes, Jutta ^b   Augustin, Wolfgang ^b   Neumann, Klaus H ^b   Luley, Claus ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b NONE

Author keywords

Atherosclerosis; CETP activity; End stage renal disease; Esterification rate; Hypertriglyceridemia; Low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; KIDNEY FAILURE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST;

EID: 0031820868     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00024.x     Document Type: Article

References (58)

1. KJELLSTRAND CM, HYLANDER B, COLLINS A: Mortality on dialysis. On the influence of early start, patients characteristics and transplantation and acceptance rates. Am J Kidney Dis 15:483-490, 1990
2. GOKAL R, KING, J, BOGLE S, MARSH F, OLIVER D, JAKUBOWSKI C, HUNT L, BAILLOD R, OGG, C, WARD M, WILKINSON R: Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4 years analysis of a prospective multicentric study. Lancet 2:1105-1109, 1987
3. UNITED STATES RENAL DATA SYSTEM: Annual data report 1990. Am J Kidney Dis 16(Suppl):S44-S52, 1990
4. World Health Annual Statistics. Geneva, Switzerland, World Health Organization, 1990, pp 166-169
5. MA KW, GREEN EL, RAIJ L: Cardiovascular risk factors in the chronicrenal failure and hemodialysis population. Am J Kidney Dis 19:505-513, 1992
6. BRUNZELL JD, ALBERS JJ, HAAS LB, GOLDBERG AP, AGADOA L, SHERRARD DJ: Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26:903-910, 1977
7. BAGDADL JD, ALBERS JJ: Plasma high density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med 296:1436-1449, 1977
8. HAAS LB, WAHL PW, SHERRARD DJ: A longitudinal study of lipid abnormalities in renal failure. Nephron 33:145-159, 1983
9. CAMEJO G, RIERA G, LEE M, LOPEZ F: Lipoprotein structural abnormalities in chronic failure with and without hemodialysis. BBA 47:239-245, 1988
10. RUBIES-PRAT J, ESPINEL E, JOVEN J, RAS MR, PIRA L: High density lipoprotein subfractions in chronic renal failure. Am J Kidney Dis 9:60-65, 1987
11. SENTI M, ROMERO R, PEDRO-BOTET J, PELEGRI A, NOGUES X, RUBIED-PRAT J: Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394-1399, 1992
12. CHAN MK, PERSAUD J, VARGHESE Z, MOORHEAD JF: Pathogenic roles of postheparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 25:812-818, 1984
13. LINDHOLM B, NORBECK HE: Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 220:143-151, 1986
14. NESTEL PJ, FIDGE NH, TAN MH: Increased lipoprotein remnant formation in chronic renal failure. N Engl J Med 307:329-333, 1982
15. RON D, OREN I, AVIRAM M, BELTER DS, BROOK JG: Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis 46:67-75, 1983
16. MCNEIL D, LEE P, MURPHY B, BEST J: Low density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis 27:84-91, 1996
17. ATTMAN PO, ALAUPOVIC P, GUSTAVSON A: Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 32:368-375, 1987
18. BERGESIO F, MONZANI G, CIUTI R, SERRUTO A, BENUCCI A, FRIZZI V, SALVADORI M: Lipids and apolipoprotein changes during the progression of chronic renal failure. Clin Nephrol 38:264-270, 1992
19. CORESH J, KWITEROVICH PO, SMITH HH, BACHORIC PS: Association of TG concentrations, LDL particle diameter, density and chemical composition with premature coronary heart disease in men and women. J Lipid Res 34:1687-1697, 1993
20. LULEY C, NEUMANN KH, WESTPHAL S, AMBROSCH A: Atherogenic effects of hemodialysis: Increased generation of small and cholesterol poor LDL particles. (abstract) Atherosclerosis 129:141, 1997
21. ORTH M, WAHL S, HANISCH M, FRIEDRICH I, WIELAND H, LULEY C: Clearance of postprandial lipoproteins in normolipidemics: Role of the apolipoprotein E phenotype. BBA 1303:22-30, 1996
22. RAINWATER DL, ANDRES DW, FORD AL, LOWE F, BLANCHE PJ, KRAUSS RM: Production of polyacrylamide gradient gels for electrophoretic resolution of lipoproteins. J Lipid Res 33:1876-1881, 1992
23. WILLIAMS PT, KRAUSS RM, NICHOLS AV, VRANIZAN KM, WOODS PDS: Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 31:1131-1139, 1990
24. TATO F, VEGA GL, GRUNDY SM: Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 17:56-63, 1997
25. AMBROSCH A, TATO F, LULEY C: Fluorescent determination of CETP activity in plasma. (abstract) Atherosclerosis 134:100, 1997
26. BROWN MS, HO YK, GOLDSTEIN JL: Cholesteryl ester cycle in macrophages. J Biol Chem 255:9344-9352, 1980
27. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL AJ: Protein measurement with the Folin-phenol reagent. J Biol Chem 193:265-275, 1951
28. KRAUSS RM, BURKE DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:236-244, 1982
29. STEWART MW, LAKER MF, DYER RG, GAME F, MITCHESON J, WINCOUR PH, ALBERT KGM: Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hypertlipidemia. Arterioscler Thromb 12:1046-1052, 1993
30. HOKANSON JE, KRAUSS RM, ALBERS JJ, AUSTIN MA, BRUNZELL JD: LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Throm Vasc Biol 15:452-459, 1995
31. CAPELL WH, ZAMBON A, AUSTIN MA, BRUNZELL JD, HOKANSON JE: Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vasc Biol 16:1040-1046, 1996
32. DECKELBAUM RJ, EISENBERG S, FAINARU M, BARENHOLZ Y, OLIVECRANO T: In-vitro production of human low density lipoprotein-like particles: A model for very low density lipoproteoin catabolism. J Biol Chem 254:6079-6087, 1979
33. KARPE F, TORNVALL T, OLIVECRANO T, STEINER G, CARSON LA, HAMSTON A: Composition of human low-density lipoprotein: Effect of postprandial triglyceride-rich lipoproteins, lipoproteine lipase, hepatic lipase and cholesterol ester transfer protein. (abstract) Atherosclerosis 98:33, 1993
34. TAN KCB, COOPER MB, LING KLE, GRIFFIN BA, FREEMAN DJ, PACKERD CJ, SHEPHERD J, HALES CN, BATTERIDGE DJ: Fasting and postprandial determinants for the occurrence of small dense LDL species in NIDDM patients with and without hypertriglyceridemia: The involvement of insulin, insulin precursor species and insulin resistance. (abstract) Atherosclerosis 113:275, 1995
35. WATSON TDG, CASLAKE DJ, FREEMAN BA, GRIFFIN BA, HINNIE J, PACKARD CJ, SHEPHERD J: Determinants of LDL subfraction distribution and concentration in young normolipidemic subjects. (abstract) Arterioscler Thromb 14:902, 1994
36. AVIRAM M, BIERMAN EL, CHAIT A: Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake of cholesterol accumulation in cell. J Biol Chem 263:15416-15422, 1988
37. DECKELBAUM RJ, EISENBERG S, OSCHRY Y, BUTBUL E, SHARON I, OLIVECRONA T: Reversible modification of human plasma low density lipoproteins towards triglyceride-rich precursors: A mechanismn for losing excess cholesterol esters. J Biol Chem 257:6509-6517, 1982
38. BAGDADE JD, RITTER MC, SUBBAIAH PV: Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 21:161-167, 1991
39. EISENBERG S: Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters. J Lipid Res 26:487-494, 1985
40. WANNER C, FROMMHERZ K, HORL WH: Hyperlipoproteinemia in chronic renal failure: Pathophysiological and therapeutical aspects. Cardiology 78:202-217, 1991
41. CHEUNG A, Wu LL, KABLITZ C, LEYPOLDT K: Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 22:271-276, 1993
42. WEINTRAUB M, BURSTEIN A, RASSIN A, LIRON M, RINGEL Y, CABILI S, BLUM M, PEER G, IAINA A: Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 42:1247-1252, 1992
43. DEGRAAF J, HAK-LEMMERS HL, HECTORS PC, DEMARKER PNM, HENDRIKS JCM, STALENHOEF AFH: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306, 1991
44. TRIBBLE DL, HOLL LG, WOOD PD, KRAUSS RM: Variation of oxidative susceptibility among six low density lipoprotein subfractions of varying size and density. Atherosclerosis 93:189-199, 1992
45. SUTHERLAND W, WALKER RJ, BALL MJ, STAPLEY S, ROBERTSON MC: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 48:227-236, 1995
46. LOUGHREY CM, YOUNG IS, MCENENY J, MCDOWELL FW, MCMASTER C, MCNAMEE PT, TRIMBLE ER: Oxidation of low density lipoprotein in patients on regular hemodialysis. Atherosclerosis 110:185-193, 1994
47. MAGGI E, BELLAZZI R, FALASCHI F, FRATTONI A, PERANI G, FINARDI G, GAZO A, NAI M, ROMANINI D, BELLOMO G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis. Kidney Int 45:876-8883, 1994
48. AGNANI G, BARD JM, CANDELIER L, DELATTRE S, FRUCHARD JC, CLAVEY V: Interaction of LpB, Lpb:E, LpB:CIII, LpB:CIII:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler Thromb 11:1021-1029, 1991
49. NICOLL A, LEWIS B: Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein matabolism: In-vivo and in-vitro studies in men. Eur J Clin Invest 10:487-495, 1980
50. Ross RN: The pathogenesis of atherosclerosis - An update. N Engl J Med 314:488-500, 1986
51. BROWN MS, GOLDSTEIN JL: The low density lipoprotein pathway and is relation to atherosclerosis. Annu Rev Biochem 52:223-261, 1983
52. MUSLINER TA, HERBERT PN, KINGSTON NJ: Lipoprotein substrates of lipoprotein lipase and hepatic triglycerol lipase from human postheparin plasma. BBA 575:277-288, 1979
53. HOMMA, Y, NAKAYA N, NAKAMURA H, GOTO Y: Increase in the density of lighter low density lipoprotein by hepatic triglyceride lipase. Artery 13:19-31, 1985
54. LAGROST L, FLORENTIN E, GUYARD-DANGREMONT V, ATHIAS A, GANDJINI H, LALLEMANT C, GAMBERT P: Evidence for nonesterified fatty acids as modulators of neutral lipid transfer in normolipidemic human plasma. Arterioscler Thromb Vasc Biol 15:1388-1396, 1995
55. LAGROST L, GAMBERT P, LALLEMENT C: Combined effects of lipid transfer and lipolysis on gradient gel patterns of human LDL. Arterioscl Thromb 14:1327-1336, 1994
56. KARPE F, TORNVALL P, OLIVECRONA T, STEINER G, CARLSON LA, HAMSTEN A: Composition of human low density lipoprotein: Effect of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 98:33-49, 1993
57. TALL AR, SAMMET D, VITA G, DECKELBAUM RJ, OLIVECRONA T: Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins. J Biol Chem 260:6687-6697, 1985
58. SAMMET D, TALL AR: Mechanismns of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 260:6687-6697